Oncodesign Precision Medicine (XPAR:ALOPM) Pre-Tax Income : € Mil (TTM As of Jun. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Oncodesign Precision Medicine's pretax income for the six months ended in Jun. 2022 was €-3.91 Mil. Oncodesign Precision Medicine does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in Jun. 2022. Oncodesign Precision Medicine's pretax margin was -890.21%.

Oncodesign Precision Medicine Pre-Tax Income Historical Data

The historical data trend for Oncodesign Precision Medicine's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Pre-Tax Income Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Pre-Tax Income

-6.25

-4.08

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22
Pre-Tax Income	-	-	-3.91

Competitive Comparison of Oncodesign Precision Medicine's Pre-Tax Income

For the Biotechnology subindustry, Oncodesign Precision Medicine's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Pre-Tax Income falls into.

Oncodesign Precision Medicine Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Oncodesign Precision Medicine's Pretax Income for the fiscal year that ended in Dec. 2021 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-3.726	+	0	+	-0.356	+	0.022	+	-0.019
	=	-4.08

Oncodesign Precision Medicine's Pretax Income for the quarter that ended in Jun. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-3.856	+	0	+	-0.06	+	0.008	+	0
	=	-3.91

Oncodesign Precision Medicine (XPAR:ALOPM) Pre-Tax Income Explanation

Oncodesign Precision Medicine's Pretax Margin for the quarter that ended in Jun. 2022 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-3.908	/	0.439
	=	-890.21%

Oncodesign Precision Medicine Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines